Healthcare Providers Brace for Enhanced Federal Fraud Enforcement Using AI

Federal authorities are intensifying their healthcare fraud investigations through advanced technologies and targeted enforcement strategies, putting providers on high alert as they navigate an increasingly complex regulatory landscape.

The Department of Justice and the Department of Health and Human Services have significantly ramped up their fraud detection capabilities, deploying artificial intelligence and sophisticated data analytics to identify suspicious billing patterns and potential violations. This technological evolution marks a substantial shift in how federal agencies approach healthcare fraud enforcement.

“We’re seeing unprecedented coordination between federal agencies,” said Rebecca Monck Ricigliano, partner at Crowell & Moring and former federal prosecutor. “The technology they’re using can now detect patterns and anomalies that would have been impossible to spot just a few years ago.”

Healthcare fraud investigations recovered approximately $5.2 billion in fiscal year 2023, up from $4.3 billion the previous year, according to HHS data. The increase reflects not only more aggressive enforcement but also more efficient detection methods that can process millions of claims to identify outliers.

The federal government’s expanding use of AI tools allows investigators to sift through vast datasets, flagging potential issues such as upcoding, medically unnecessary procedures, and kickback arrangements. These tools can identify patterns across providers, specialties, and geographic regions, creating a more comprehensive picture of potential fraud schemes.

For providers, particularly smaller practices and rural facilities, this heightened scrutiny creates significant compliance challenges. Many are investing in their own compliance programs and technology solutions to prevent inadvertent violations.

“The reality is that not all billing errors constitute fraud,” explained Jennifer Weaver, healthcare compliance attorney with Baker Donelson. “But in this environment, even honest mistakes can trigger investigations that are costly and disruptive to healthcare operations.”

Telehealth has emerged as a particular focus for federal investigators following the COVID-19 pandemic’s rapid expansion of virtual care services. The temporary regulatory flexibilities implemented during the public health emergency created opportunities for fraudulent schemes, leading to several major telehealth fraud takedowns in recent years.

In July 2023, the Justice Department charged over 40 defendants across multiple states in a $1.4 billion telehealth fraud scheme involving unnecessary genetic testing and durable medical equipment prescriptions. The case highlighted how quickly fraudulent operations can scale in the telehealth environment.

Federal authorities have also sharpened their focus on Medicare Advantage organizations and their risk adjustment practices. Several major insurers have faced investigations regarding potentially inflated risk scores that increase payments from the government.

“The government is looking very closely at documentation practices and how conditions are being coded,” said Katherine Lauer, healthcare partner at Latham & Watkins. “This is a high-priority area where we expect to see continued enforcement activity.”

Mental health and substance use disorder treatment facilities have similarly come under increased scrutiny, particularly those receiving funds through federal programs targeting the opioid crisis. Investigators are examining patient brokering arrangements, inaccurate billing for services, and quality of care issues.

Healthcare industry groups have expressed concern about the aggressive enforcement environment, arguing that well-intentioned providers may be caught in the crossfire. The American Hospital Association recently called for more clarity regarding compliance expectations and greater distinction between fraud and unintentional billing errors.

To protect themselves, providers are implementing more robust compliance programs, conducting regular internal audits, and investing in staff training. Many larger healthcare organizations are also developing their own analytics capabilities to identify potential compliance issues before they appear on federal investigators’ radar.

“The best defense is a good offense,” advised Mark Silberman, chair of the healthcare practice at Benesch Law. “Providers need to be proactive about compliance, conduct thorough risk assessments, and address vulnerabilities before they become problems.”

As federal enforcement continues to intensify, healthcare experts recommend that providers maintain detailed documentation, regularly review coding and billing practices, and ensure that clinical decision-making is clearly supported by medical necessity. Organizations facing investigations should engage specialized legal counsel early in the process.

The evolving enforcement landscape represents a significant challenge for the healthcare industry, but also potentially benefits patients by reducing fraud that drives up costs and sometimes compromises care quality. Finding the balance between vigorous fraud prevention and allowing providers to focus on their core mission of patient care remains the central challenge for both regulators and the healthcare community.